Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Completed × Vitamin D × Clear all

Phase

Phase NA 14 Phase 2 12 Phase 3 11 Phase 1/2 4 Phase EARLY_PHASE1 3 Phase 4 3 Phase 1 3 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cisplatin 19 Fluorouracil 17 Gemcitabine 14 Radiotherapy 13 Paclitaxel 13 Docetaxel 13 Oxaliplatin 12 Cyclophosphamide 11 Carboplatin 11 Capecitabine 11 Bevacizumab 11 Drug Therapy 10 Leucovorin 9 Cytarabine 9 Irinotecan 8 Magnetic Resonance Spectroscopy 7 Dexamethasone 7 Saline Solution 6 Methotrexate 6 Letrozole 6 Exercise 6 Etoposide 6 pembrolizumab 5 Rituximab 5 Nivolumab 5 Melphalan 5 Lidocaine 5 Filgrastim 5 Electroporation 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03103152 2023-03-29

PROVENT

Queen Mary University of London

Phase 2/3 Completed

104 enrolled 14 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡